DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Assets | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
What is the latest Total Assets ratio of DIVIS LABORATORIES ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹17,717 Cr |
| Mar2024 | ₹15,937 Cr |
| Mar2023 | ₹14,863 Cr |
| Mar2022 | ₹14,619 Cr |
| Mar2021 | ₹11,387 Cr |
How is Total Assets of DIVIS LABORATORIES Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹17,717 Cr | 11.17 | |
| Mar2024 | ₹15,937 Cr | 7.23 | |
| Mar2023 | ₹14,863 Cr | 1.67 | |
| Mar2022 | ₹14,619 Cr | 28.39 | |
| Mar2021 | ₹11,387 Cr | - | |
Compare Total Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹174,227.7 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,642.0 Cr | -2% | 2.7% | 7.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
-3.5% |
1.8% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses